Plans to restrict access to drugs will put vulnerable patients at risk, BMA arguesBMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k1115 (Published 08 March 2018) Cite this as: BMJ 2018;360:k1115
- Gareth Iacobucci
- The BMJ
Proposals to restrict access to drugs that can be bought over the counter for minor, short term conditions will put vulnerable patients at risk, the BMA has warned.
NHS England is consulting on plans to issue national guidance to clinical commissioning groups (CCGs) on limiting GPs’ prescribing of over-the-counter products for 35 minor or self limiting conditions, as part of a push to save money and tackle unwarranted variation in prescribing.12
But in its response to the consultation, which closes on 14 March, the BMA said that the proposals would …